Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomics of cytokine-treated human colonic epithelial organoids

ABSTRACT: Mapping of transcriptional changes elicited by cytokines mediating canonical immune responses in human colonic organoids

ORGANISM(S): Homo sapiens

PROVIDER: GSE190634 | GEO | 2022/08/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptomics of IL9 and IL13-treated human colonic epithelial organoids

Project description:Mapping of transcriptional changes elicited by cytokines mediating Th2 and Th9 responses in human colonic organoids

2022-08-08 | GSE190705 | GEO

Transcriptomics of cytokine-treated human colonic epithelial organoids

Project description:Transcriptomics of cytokine-treated human colonic epithelial organoids

| PRJNA787886 | ENA

VDR ChIP-Seq on colonic human organoids

Project description:Genome-wide maps of VDR binding sites in colonic organoids estimulated with calcitriol

2019-07-21 | GSE107283 | GEO

Transcriptomics of IL9 and IL13-treated human colonic epithelial organoids

Project description:Transcriptomics of IL9 and IL13-treated human colonic epithelial organoids

| PRJNA788129 | ENA

Genomic and epigenomic responses to aspirin in human colonic organoids

Project description:Background & Aims: Aspirin (ASA) is a proven chemoprotective agent for colorectal cancer; yet, mechanisms underlying these effects are incompletely understood. Human organoids are an ideal system to study genomic and epigenomic host-environment interactions. Here, we utilize human colonic organoids to profile ASA responses on genome-wide gene expression and chromatin accessibility. Methods: Human colonic organoids from one individual were cultured and treated in triplicate with 3mM ASA or vehicle control (DMSO) for 24 hours. Gene expression and chromatin accessibility were measured using RNA- and ATAC-sequencing, respectively. Differentially expressed genes were analyzed using DESeq2. Gene set enrichment was performed by SetRank. Differentially accessible peaks were analyzed using DiffBind and EdgeR. Motif enrichment was determined using HOMER and diffTF. Results: The results yielded strong transcriptional responses to ASA treatment with significant enrichment for fatty acid oxidation and PPAR signaling in the normal colonic epithelium that were validated in independent organoid lines. A large number of differentially accessible chromatin regions were found in response to ASA treatment with significant enrichment for Fos, Jun and Hnf transcription factor motifs. Integrated analysis of epigenomic and genomic treatment responses highlighted genes and regulatory regions that could mediate ASA’s specific effects in the colon including those involved in chemoprotection and/or toxicity. Conclusions: Assessment of chromatin accessibility and transcriptional responses to ASA yielded new observations about genome-wide effects in the colon facilitated by application of human colonic organoids. This framework can be applied to study colonic ASA responses between individuals and populations in future.

2023-01-01 | GSE198434 | GEO

VDR ChIP-Seq on colonic human organoids

Project description:VDR ChIP-Seq on colonic human organoids

| PRJNA419552 | ENA

Bulk RNA-seq of Mouse Colonic Organoids: SATB2 and FOXD2KO CRISPR Knockout

Project description:CRISPR knock out the Satb2 or Foxd2 gene from mouse colonic organoids to validate core human and mouse large intestine stem cell enrich TFs.

2021-10-05 | GSE167283 | GEO

Vitamin D receptor (VDR) ChIP-Seq on human colonic organoids stimulated with 1,25(OH)2D3

Project description:Genome-wide VDR chromatin binding sites in colonic organoids stimulated with 1,25(OH)2D3 for 2h.

2024-07-01 | GSE206176 | GEO

RNA-Seq: The transcriptional response to 1,25(OH)2D3 in human colonic organoids

Project description:Colonic organoids generated from one healthy individual were treated with 1,25(OH)2D3 or vehicle for 6 and 24h. Differential expressed genes are compared across treatments.

2024-07-01 | GSE206177 | GEO

Brd4 knockout colonic epithelial organoids are partially resistant to IFNg-induced cell death.

Project description:To identify the role of Brd4 in colorectal cancer (CRC) development , we performed Sleeping Beauty (SB) transposon mutagenesis in mice. We identified several candidate genes including Brd4. To provide functional validation, we knocked out Brd4 in mouse tumor organoids carrying an activating KrasG12D, and an inactivating ApcD716 allele, and performed RNAseq. Brd4 knockout colonic organoids showed deregulation of genes in IFNg signaling. We treated Brd4 knockout organoids with IFNg and found that Brd4 konckout organoids showed partial resistance to IFNg-induce cell death. The mechanism may explain the function of Brd4 in colon cancer development.

2024-11-24 | GSE248821 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data